These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 23339751)

  • 61. The reporting of safety among drug systematic reviews was poor before the implementation of the PRISMA harms checklist.
    Li L; Xu C; Deng K; Zhou X; Liu Z; Busse JW; Ren Y; Zou K; Sun X
    J Clin Epidemiol; 2019 Jan; 105():125-135. PubMed ID: 30278212
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Adherence to conflicts of interest policy in Cochrane reviews where authors are also editorial board members: A cross-sectional analysis.
    Pacheco RL; Latorraca COC; Martimbianco ALC; Miranda E; Fontes LES; Nunan D; Riera R
    Res Synth Methods; 2022 Jan; 13(1):6-11. PubMed ID: 34165922
    [TBL] [Abstract][Full Text] [Related]  

  • 63. When is the evidence conclusive? Analysis of systematic reviews for which Cochrane declared that conclusions will not change with further studies.
    Babić A; Poklepović Peričić T; Pieper D; Puljak L
    Res Synth Methods; 2022 Jul; 13(4):478-488. PubMed ID: 35278034
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Quality of life assessment in core outcome sets: A position statement of the EADV Task Force on Quality of Life and Patient Oriented Outcomes.
    Chernyshov PV; Evers AWM; Bewley A; Tomas-Aragones L; Marron SE; Manolache L; Pustišek N; Abeni D; Sampogna F; Linder MD; Salek MS; Szepietowski JC
    J Eur Acad Dermatol Venereol; 2022 Jan; 36(1):20-23. PubMed ID: 34687091
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Cochrane summary of findings: horse chestnut seed extract for chronic venous insufficiency.
    Underland V; Sæterdal I; Nilsen ES
    Glob Adv Health Med; 2012 Mar; 1(1):122-3. PubMed ID: 24278808
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Intervention synthesis: a missing link between a systematic review and practical treatment(s).
    Glasziou PP; Chalmers I; Green S; Michie S
    PLoS Med; 2014 Aug; 11(8):e1001690. PubMed ID: 25117057
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The effect of probiotics for preventing acute upper respiratory tract infections.
    Sæterdal I; Underland V; Nilsen ES
    Glob Adv Health Med; 2012 May; 1(2):124-5. PubMed ID: 24278820
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Hand hygiene for the prevention of infections in neonates.
    Kuti BP; Ogunlesi TA; Oduwole O; Oringanje C; Udoh EE; Meremikwu MM
    Cochrane Database Syst Rev; 2021 Jul; 7(7):CD013326. PubMed ID: 34228360
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Enhancing the Interpretation of Continuous Outcomes and Subgroup Analyses in Systematic Reviews-Reply.
    Zhou T; Luo Y; Zhang J
    JAMA Pediatr; 2024 Jun; 178(6):627-628. PubMed ID: 38648025
    [No Abstract]   [Full Text] [Related]  

  • 70. What still remains missing from participants' selection criteria in clinical trials and systematic reviews?
    Miller CS; Carrasco-Labra A; Farag AM; Ariyawardana A; Albuquerque R; Chmieliauskaite M; Glick M
    J Am Dent Assoc; 2018 Nov; 149(11):931-934. PubMed ID: 30724166
    [No Abstract]   [Full Text] [Related]  

  • 71. Editors' Choice May 2022: Evidence-Based-Research, Surrogate Outcomes and Exclusion of Old Systematic Reviews in Meta-analyses.
    Tugwell P; Tovey D
    J Clin Epidemiol; 2022 May; 145():A4-A5. PubMed ID: 35738698
    [No Abstract]   [Full Text] [Related]  

  • 72. Introduction to the Theme "New Insights, Strategies, and Therapeutics for Common Diseases".
    Insel PA; Blaschke TF; Amara SG; Meyer UA
    Annu Rev Pharmacol Toxicol; 2022 Jan; 62():19-24. PubMed ID: 34606327
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Implementing systematic reviews of prognosis studies in Cochrane.
    Moons KG; Hooft L; Williams K; Hayden JA; Damen JA; Riley RD
    Cochrane Database Syst Rev; 2018 Oct; 10(10):ED000129. PubMed ID: 30306538
    [No Abstract]   [Full Text] [Related]  

  • 74. Mortality Outcomes in Dermatology: An Exploration of Core Outcome Sets and Cochrane Skin Systematic Reviews.
    Sivesind TE; Szeto MD; Hassan S; Tugwell P; Dellavalle RP
    JMIR Dermatol; 2022 Feb; 5(1):e34140. PubMed ID: 37632866
    [No Abstract]   [Full Text] [Related]  

  • 75. Attack of zombie reviews? JBI Evidence Synthesis editors discuss the commentary "Definition, harms, and prevention of redundant systematic reviews".
    Stern C; Hines S; Leonardi-Bee J; Slyer J; Wilson S; Carrier J; Wang N; Aromataris E
    JBI Evid Synth; 2024 Mar; 22(3):359-363. PubMed ID: 38352984
    [No Abstract]   [Full Text] [Related]  

  • 76. Learning to See Spin in Systematic Reviews.
    Helfand M
    Ann Intern Med; 2024 Aug; 177(8):1132. PubMed ID: 39008859
    [No Abstract]   [Full Text] [Related]  

  • 77.
    Leslie SR
    Biophys Rev; 2022 Apr; 14(2):417-421. PubMed ID: 35437452
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Using Predictive Analytics to Improve Healthcare Outcomes. John W. Nelson, Lead Editor: Jayne Felgen and Mary Ann Hozak, Co-Editors. Wiley, 2021, 464 pages.
    Wei H
    Creat Nurs; 2022 Feb; 28(1):74-76. PubMed ID: 35173066
    [No Abstract]   [Full Text] [Related]  

  • 79. From the Co-Editors.
    Sena Moore K; LaGasse B
    J Music Ther; 2022 Dec; 59(4):341-343. PubMed ID: 36527698
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.